Fund innovators at their inflection point
We invest in companies and technologies with unique and significant potential to challenge or change their industries, creating tremendous opportunities for value creation and capital appreciation.
Active investment & involvement
We take an active role in fostering our portfolio companies’ growth by providing strategic guidance, offering operational insight, and forging relationships with select partners to help them sharpen their business and market position.
Driving growth & successful exits
With our engaged approach, we accelerate value creation and help our portfolio companies achieve maximum valuation upon exit, thereby creating superior returns for company founders, employees, and growth-oriented equity investors.
Tenets of Success
How We Deliver Results
Invest at rational valuations and build substantive ownership positions.
Empower management through performance metrics and solid governance.
Balance technology risk through thoughtful and diligent execution.
Work closely with portfolio companies to strategically position for maximum valuation.
Resources and Portfolio Updates
Explore our investment resources and updates from our portfolio companies.
RedShiftBio Launches Aurora TX: Revolutionizing RNA and Protein Analysis with Ultra-Sensitive Microfluidic Modulation Spectroscopy and Thermal Ramping Capability
Boxborough, MA, May 13, 2024– RedShiftBio, a leader in innovative biophysical characterization and bioprocess analytical solutions, proudly announces the launch of Aurora TX at The Protein & Antibody Engineering Summit (PEGS), kicking off on May 13,2024, in Boston, MA. Aurora TX is the company’s latest, most advanced instrument featuring ground-breaking MMS technology, and sets a new standard in biomolecular analysis by providing ultra-sensitive, ultra-precise measurements of biomolecule structure and stability, now enhanced with the addition of thermal ramping capability.
Read More...Navisun and Ampion Partner to Deliver Community Solar Savings to Customers and Expand to New Markets Across the U.S.
The long-term partnership begins with the construction of five distributed generation projects for commercial, industrial, and residential customers throughout the Northeast and Midwest.
Read More...ARTRON AMERICA, INC. and BrightView Technologies collaborate to enhance MLA solutions in Automotive Industry
Research Triangle Park, NC – August 29, 2024 – BrightView Technologies and ARTRON AMERICA, INC. have partnered to provide next-generation MLA optics and diffuser solutions to the automotive industry in Japan and around the world. Today’s automobile manufacturers face the tough challenge of increasingly advanced displays and aesthetic vehicle lighting while simultaneously needing to achieve new levels of efficient power consumption and performance.
Read More...7SIGNAL Achieves SOC 2 Type 2 Compliance, Elevating Its Commitment to Data Security and Privacy
Cleveland, OH] — 7SIGNAL, the leader in enterprise Wi-Fi optimization, proudly announces that it has successfully attained SOC 2 Type 2 compliance certification. This achievement not only reinforces 7SIGNAL's dedication to the highest data security and privacy standards but also demonstrates its commitment to operational excellence and reliability.
Read More...Elevation Spine, Inc. Closes $11 Million Series B Financing
MONTEREY, Calif., Sept. 19, 2022 --Elevation Spine, Inc., the leading innovator of integrated-fixation spinal technologies, today announced the completion of its Series B Preferred Stock financing, totaling $11 million. The funding was led by Technology Venture Partners (“TVP”) and included participation from Mutual Capital Partners (“MCP”) and existing investors. The company also announced the appointment of Donald Bossi and Bryson Hollimon, both of Technology Venture Partners, to its Board of Directors.
Read More...Raven360 Closes $8 Million Series B Financing
MARLBOROUGH, Mass., Aug. 4, 2022 -- Raven360, the leader in customer journey acceleration solutions, announced the closing of an $8 million Series B funding round. The round was led by new investors Technology Venture Partners and Allos Ventures, joined by prior investors Nauta Capital and NXT Ventures.
Read More...RedShift BioAnalytics Closes $20M Series E Funding Led by Illumina Ventures
BURLINGTON, Mass., Oct. 18, 2021 -- RedShift BioAnalytics Inc. (RedShiftBioⓇ), a company providing next-generation platform technology enabling measurement of previously undetectable structure changes in biomolecules, announced today the closing of its Series E Preferred Stock financing. The $20 million financing was led by Illumina Ventures and joined by all of the company’s current major investors, including Technology Venture Partners and Waters Corporation. Proceeds of the financing will be used to fund additional commercial expansion, continued technology innovation, and execution of its product development objectives.
Read More...Ampion PBC Closes $10M Series A Preferred Stock Financing
BOSTON, Feb. 16, 2021 -- Ampion PBC, the revenue-management software platform solution for Community Solar and other Distributed Generation Assets, today announced it has completed a $10M Series A Preferred Stock financing. The investment, provided by Technology Venture Partners (TVP), will support and finance the company's accelerating growth. In addition to providing the financing Managing General Partner, Bryson Hollimon and General Partner, Don Bossi will join Ampion's Board of Directors.
Read More...7SIGNAL Recognized in Gartner’s Market Guide for Digital Experience Monitoring
Cleveland, OH – 7SIGNAL®, the leader in enterprise wireless experience monitoring, today announced that it has been recognized in the Gartner “Market Guide for Digital Experience Monitoring” report. 7SIGNAL was named a Representative Vendor in the Endpoint Monitoring Technologies category.
Read More...Peer-reviewed study demonstrates higher sensitivity, repeatability, and utility relative to conventional FTIR.
Burlington, MA - October 05 2020, A new collaborative study from RedshiftBio (Burlington, MA) and a Major Pharmaceutical Company published in the Journal of Pharmaceutical Sciences provides compelling evidence of the benefits of the award winning AQS3™pro, a Microfluidic Modulation Spectroscopy platform from RedShift BioAnalytics, Inc., for the biopharmaceutical industry.
Read More...7SIGNAL Announces Portable Enterprise-Grade Wireless Monitoring Appliance
Cleveland, OH – 7SIGNAL®, the leader in enterprise wireless experience monitoring, today announced the general availability of the Sapphire Eye® 250 wireless monitoring appliance. The high-performance hardware, acts as a portable Wi-Fi sensor addressing the industry need for optimized user experiences across application environments and the alignment of technology KPIs to business metrics.
Read More...Approach Improves Wireless Device Performance When Moving Between Wi-Fi Access Points and Networks
CLEVELAND - 7SIGNAL®, the leader in enterprise Wireless Network Monitoring (WNM), has been issued U.S. patent number 10,638,409 for Wi-Fi roaming management. The patent covers 7SIGNAL’s approach to using its Mobile EyeTM software on a wireless device to detect, assess and improve the performance of clients as they move from one Wi-Fi access point or to a cellular network.
Read More...